Trial intelligence / Profile preview

Budesonide vs Fluticasone on Adrenal Function in COPD

NCT01186653Phase 4Completed

Sponsor
Hull University Teaching Hospitals
Start
Oct 2007
Primary completion
May 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of budesonide, salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by Hull University Teaching Hospitals. Started Oct 2007; status: completed.

02

Drugs

budesonidesalmeterol + fluticasone
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01186653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01186653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call